Related Experiment Video
Updated: May 25, 2026
10:55
Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance
Published on: October 16, 2018
Measurement of VLA-4/CS-1 and VLA-4/VCAM adhesion inhibition
1University of Washington, Seattle, Washington, USA.
Current Protocols in Pharmacology
|February 2, 2012
Summary
This study details methods for measuring compounds that inhibit VLA-4-mediated cell adhesion, a key step in inflammation targeted by drug discovery.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Cell adhesion is a crucial early event in inflammatory processes.
- Targeting cell adhesion molecules presents a significant opportunity for drug discovery.
- Vascular cell adhesion molecule (VCAM) and fibronectin are key mediators of inflammatory cell adhesion.
Purpose of the Study:
- To describe techniques for measuring inhibitors of VLA-4-mediated cell adhesion.
- To provide methods for assessing inhibition of adhesion to VCAM and fibronectin's CS-1 segment.
Main Methods:
- Assays were developed to quantify VLA-4-mediated cell adhesion.
- Inhibitory effects of compounds on adhesion to VCAM and CS-1 were measured.
- Techniques focus on the interaction between VLA-4 and its ligands.
Main Results:
- Established reliable methods for measuring VLA-4/VCAM and VLA-4/CS-1 adhesion.
- Demonstrated the utility of these assays in identifying potential anti-inflammatory agents.
- Quantified the inhibitory potential of various compounds.
Conclusions:
- The described techniques are valuable for drug discovery efforts targeting inflammation.
- Inhibiting VLA-4-mediated adhesion is a promising therapeutic strategy.
- These methods facilitate the identification and development of novel anti-inflammatory drugs.
